P2RY13 Primary Antibody

Item Information
Catalog #Size/ConcentrationPrice
Specification
AliasesGPCR1; GPR86; GPR94; P2Y13; SP174; FKSG77
ProductOrderP
Clone#2H1G9
Entrez GenelD53829
FormulationAscitic fluid containing 0.03% sodium azide.
HostMouse
IsotypeIgG1
ImmunogenPurified recombinant fragment of human P2RY13 (AA: 1-49) expressed in E. Coli.
MW40.8kDa
Shipping InformationThis product will ship in a box containing blue ice at a temperature of 4°C. Learn More
Species ReactivityHuman
Application
ELISA1/10000
FCM (Flow Cytometry)1/200 - 1/400
WB (Western Blot)1/500 - 1/2000
Sequence
N
Catalog#: 30487
Inquire
Contact us to order
Images
Western Blot
Figure 1: Western blot analysis using P2RY13 mAb against human P2RY13 recombinant protein. (Expected MW is 31.6 kDa)
Figure 1: Western blot analysis using P2RY13 mAb against human P2RY13 recombinant protein. (Expected MW is 31.6 kDa)
Western Blot
Figure 2: Western blot analysis using P2RY13 mAb against HEK293 (1) and P2RY13 (AA: 1–49)-hIgGFc transfected HEK293 (2) cell lysate.
Figure 2: Western blot analysis using P2RY13 mAb against HEK293 (1) and P2RY13 (AA: 1–49)-hIgGFc transfected HEK293 (2) cell lysate.
Flow cytometric
Figure 4: Flow cytometric analysis of HepG2 cells using P2RY13 mouse mAb (green) and negative control (purple).
Figure 4: Flow cytometric analysis of HepG2 cells using P2RY13 mouse mAb (green) and negative control (purple).
Elisa
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Product Overview
DescriptionThe product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is activated by ADP.
References (references)
References (references)1. J Pharmacol Exp Ther. 2002 May;301(2):705-13.
2. Mol Biotechnol. 2008 Jul;39(3):239-64.